Seattle Institute’s Coronavirus Treatment Study Gets Quick FDA Approval

A potentially groundbreaking novel coronavirus treatment being explored by Seattle’s Infectious Disease Research Institute has received FDA approval to start human trials. Dr. Corey Casper, the Institute’s CEO hopes the trials can be completed within 11 months.

READ THE ARTICLE in The Seattle Times »